- Home
- CKX vs BCAB Comparison
CKX vs BCAB Comparison
Compare CKX & BCAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CKX
- BCAB
- Stock Information
- Founded
- CKX 1930
- BCAB 2007
- Country
- CKX United States
- BCAB United States
- Employees
- CKX N/A
- BCAB N/A
- Industry
- CKX Oil & Gas Production
- BCAB Medicinal Chemicals and Botanical Products
- Sector
- CKX Energy
- BCAB Health Care
- Exchange
- CKX Nasdaq
- BCAB Nasdaq
- Market Cap
- CKX 23.7M
- BCAB 21.0M
- IPO Year
- CKX 1998
- BCAB 2020
- Fundamental
- Price
- CKX $12.00
- BCAB $0.36
- Analyst Decision
- CKX
- BCAB Buy
- Analyst Count
- CKX 0
- BCAB 2
- Target Price
- CKX N/A
- BCAB $1.00
- AVG Volume (30 Days)
- CKX 7.8K
- BCAB 729.6K
- Earning Date
- CKX 08-22-2025
- BCAB 08-07-2025
- Dividend Yield
- CKX N/A
- BCAB N/A
- EPS Growth
- CKX N/A
- BCAB N/A
- EPS
- CKX 0.18
- BCAB N/A
- Revenue
- CKX $835,960.00
- BCAB $11,000,000.00
- Revenue This Year
- CKX N/A
- BCAB N/A
- Revenue Next Year
- CKX N/A
- BCAB N/A
- P/E Ratio
- CKX $66.11
- BCAB N/A
- Revenue Growth
- CKX N/A
- BCAB N/A
- 52 Week Low
- CKX $10.04
- BCAB $0.24
- 52 Week High
- CKX $14.00
- BCAB $2.53
- Technical
- Relative Strength Index (RSI)
- CKX 58.62
- BCAB 48.29
- Support Level
- CKX $11.56
- BCAB $0.34
- Resistance Level
- CKX $12.00
- BCAB $0.39
- Average True Range (ATR)
- CKX 0.20
- BCAB 0.03
- MACD
- CKX -0.05
- BCAB 0.00
- Stochastic Oscillator
- CKX 39.64
- BCAB 41.01
About CKX CKX Lands Inc.
CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership of oil and gas royalties, surface leases for farming, the right of way and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells, and timber income is paid by the highest bidder for the timber. CKX has small royalty interests in approximately 20 different producing oil and gas fields. Maximum revenue for the company is generated from the Surface segment. Geographically, it generates all of its revenue from the United States of America.
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.